Expert Opinion on Biological Therapy

Summary

Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974.[1] The journal is also indexed in MEDLINE.

Expert Opinion on Biological Therapy
DisciplineTherapeutics
LanguageEnglish
Edited byMichael Morse
Publication details
History2001-present
Publisher
FrequencyMonthly
3.974 (2017)
Standard abbreviations
ISO 4Expert Opin. Biol. Ther.
Indexing
ISSN1471-2598 (print)
1744-7682 (web)
LCCN2001243388
OCLC no.48476209
Links
  • Journal homepage
  • Online access
  • Online archive

References edit

  1. ^ "Expert Opinion on Biological Therapy". 2017 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2018.

External links edit

  • Official website